#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medullary thyroid cancer Keratosis follicular Cerebral amyloid angiopathy Primary hyperoxaluria Neurotrophic keratopathy Primary amyloidosis Liposarcoma metastatic Carcinoid tumour Giant cell tumour of tendon sheath Haemophilia B without inhibitors Ehlers-Danlos syndrome Thrombocytopenia Marginal zone lymphoma Thymic carcinoma Lymphangiosarcoma More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Trials in Disease Acute respiratory distress syndrome – Treatment Fabry’s disease – Diagnostics Primary biliary cholangitis – Diagnostics Focal segmental glomerulosclerosis – Trials in Disease Friedreich’s ataxia – Diagnostics Antithrombin III deficiency – Treatment Toxic epidermal necrolysis – Diagnostics Mast cell activation syndrome – Trials in Disease Systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SEVABERTINIB Carcik-Cd19 Cells Antiemetics And Antinauseants Procarbazine Naproxen Sodium Alglucosidase Alfa Migalastat Amitriptyline Levobupivacaine Hydrochloride 19Cp02 Rosnilimab Elenestinib Phosphate Caraway Oil Leuprorelin Acetate Wt1 Lamp Mrna Dc Imlifidase FIBRIN Transpocart19 GSKVX000000034795 Protein S More therapies…

    Learn about Your Condition

    Infertility female Pyelonephritis acute Adenovirus infection Follicular thyroid cancer Plasma cell myeloma Peritoneal neoplasm Pneumothorax Endometrial cancer metastatic Thymic carcinoma Dry mouth Acute myocardial infarction Endocarditis bacterial Stress cardiomyopathy Arthralgia Naevoid melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pyoderma gangrenosum

  • Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

    Recruiting

    3 1
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Finland France Germany Italy +5

  • Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pyoderma gangrenosum
    Investigated Drugs:
    • Cortisone Acetate
    • Triamcinolone
    • Vilobelimab
    Belgium France Germany Hungary Italy The Netherlands +2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!